What about Able Nord (Beijing) Medical Technology Co.

Introduction: ABNORD (Beijing) Medical Technology Co., Ltd. is a company that provides ophthalmic medical services and products, simply put, it is a company that integrates an eye hospital and the research and development of ophthalmic medical products with an integrated enterprise.

Legal representative: Xie Jiangbing

Establishment date: 2010-04-21

Registered capital: 78,842,927,130,000 RMB

Region: Beijing

Unified social credit code: 9111011455135477XA

Business status: open

Industry: scientific research and technology services

Company type: limited liability company (sino-foreign equity joint venture)

English name: Eyebright (Beijing) Medical Technology Co.,Ltd.

Personnel size: 100-499 people

Business address: North Zone, First Floor, Building 6, No. 37 Chaoqian Road, Changping District, Beijing

Business Scope: production and sales of medical devices and their accessories; production of pharmaceuticals; retail of pharmaceuticals; technological development, technology transfer, technical consulting, and technical services for disinfection products, hygiene products, and contact lens care products (excluding human stem cell, gene diagnosis and treatment technology development and application); medical research and experimental development (excluding Medical research and experimental development (excluding human stem cells, gene diagnosis and treatment technology development and application); chemical products (excluding hazardous chemicals), machinery and equipment and accessories, instruments and accessories, medical equipment (Class I) wholesale, import and export of goods, technology import and export, import and export agency, commission agent (does not involve the management of state trade commodities; commodities involved in the management of quotas and licenses in accordance with the relevant provisions of the State for application procedures). (Enterprises in accordance with the law to independently choose business projects, to carry out business activities; production of drugs, retail drugs and projects subject to approval by law, approved by the relevant departments to carry out business activities in accordance with the approved content.)